Covid-19 Drug Racket: Pharma firm MD and 7 others busted

HYDERABAD: A Pharma firm MD and 7 othersin Hyderabad who were Black-marketing the covid-19 drugs were arrested by the Task Force. A chain of middlemen was used by the gang to supply drugs to patients.

K Venkata Subramanyam alias Phani, the MD of Sri Medicure Products (OPC) Private Limited, revealed that he procured drugs like Remdesivir and FabiFlu from the Hetero Pharma unit in Sangareddy district.

A drug, Tocilizumab, was also procured through Gagan Khurana (21), a Delhi- based supplier. Whatsapp platform was used by the gang and the business was running from past one month. The gang also accepted cash and UPI payment. “Drugs worth Rs 35 were seized from their possession”, according to Hyderabad Police Commissioner Anjani Kumar.
Police further said that, “K Venkata Subramanyam used to sold the drug first to Santosh Kumar. Afterwards, it changed many people till it reached the client. A margin of around Rs 4,000 were kept by each person. Inquiries also revealed that Remdesivir is available at Rs 5,400 per unit, but the gang members used to sale it for around Rs 40,000 and Tocilizumab which costs Rs 40,000 per unit, was being sold for more than Rs 1 lakh.

These drug is used to treat Covid-19 patients who are in the ventilator stage. Several patients who purchased the drug from the gang have been recovered. who Supplier of Tocilizumab to Phani, Gagan Khurana flew away to the city to deliver the medicines when he was arrested. Police officials are further investigating whether the gang supplied drugs in neighboring states as well.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India